Search Results

There are 12941 results for: content related to: Comparison of Increasing Doses of Olmesartan Medoxomil, Losartan Potassium, and Valsartan in Patients With Essential Hypertension

  1. You have free access to this content
    Clinical and Experimental Aspects of Olmesartan Medoxomil, a New Angiotensin II Receptor Antagonist

    Cardiovascular Drug Reviews

    Volume 22, Issue 4, December 2004, Pages: 285–308, Kazunori Yoshida and Masahiro Kohzuki

    Version of Record online : 7 JUN 2006, DOI: 10.1111/j.1527-3466.2004.tb00147.x

  2. Immunopathogenesis of olmesartan-associated enteropathy

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 11-12, December 2015, Pages: 1303–1314, E. V. Marietta, A. M. Nadeau, A. K. Cartee, I. Singh, A. Rishi, R. S. Choung, T.-T. Wu, A. Rubio-Tapia and J. A. Murray

    Version of Record online : 1 OCT 2015, DOI: 10.1111/apt.13413

  3. You have free access to this content
    A Review of Olmesartan Medoxomil Monotherapy: Antihypertensive Efficacy Similar to That of Other Angiotensin II Receptor Blocker/Hydrochlorothiazide Combinations?

    Congestive Heart Failure

    Volume 8, Issue 6, November/December 2002, Pages: 313–320, Mark Greathouse

    Version of Record online : 12 JUN 2007, DOI: 10.1111/j.1527-5299.2002.02077.x

  4. Pharmacokinetics of Amlodipine and Olmesartan After Administration of Amlodipine Besylate and Olmesartan Medoxomil in Separate Dosage Forms and as a Fixed-Dose Combination

    The Journal of Clinical Pharmacology

    Volume 48, Issue 11, November 2008, Pages: 1309–1322, Dr Shashank Rohatagi, Dr James Lee, Dr Magdy Shenouda, Dr Stephen Haworth, Dr Mohinder Singh Bathala, Dr Mark Allison, Dr Igor Rubets, Dr Reinilde Heyrman, Dr Robert Noveck and Dr Daniel E. Salazar

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008322176

  5. Sustained 24-hour blockade of the renin-angiotensin system: A high dose of a long-acting blocker is as effective as a lower dose combined with an angiotensin-converting enzyme inhibitor

    Clinical Pharmacology & Therapeutics

    Volume 78, Issue 5, November 2005, Pages: 501–507, Christopher Hasler, Jürg Nussberger, Marc Maillard, Andrei Forclaz, Hans R. Brunner and Michel Burnier

    Version of Record online : 18 NOV 2005, DOI: 10.1016/j.clpt.2005.08.001

  6. You have free access to this content
    Antihypertensive Efficacy of Olmesartan Medoxomil, a New Angiotensin II Receptor Antagonist, as Assessed by Ambulatory Blood Pressure Measurements

    The Journal of Clinical Hypertension

    Volume 4, Issue 5, September/October 2002, Pages: 325–331, Joel M. Neutel, 1 William J. Elliott, 2 Joseph L. Izzo Jr., 3 Chao L. Chen and 4 Harvey N. Masonson 4

    Version of Record online : 31 MAY 2007, DOI: 10.1111/j.1524-6175.2002.01051.x

  7. Evaluation of Population Pharmacokinetics and Exposure-Response Relationship With Coadministration of Amlodipine Besylate and Olmesartan Medoxomil

    The Journal of Clinical Pharmacology

    Volume 48, Issue 7, July 2008, Pages: 823–836, Dr Shashank Rohatagi, Dr Timothy J. Carrothers, Dr Smita Kshirsagar, Dr Tatiana Khariton, Dr James Lee and Dr Daniel Salazar

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008317847

  8. You have free access to this content
    Antihypertensive Drugs and Pharmacology

    The Journal of Clinical Hypertension

    Volume 10, Issue 5SA, May 2008, Pages: A6–A37,

    Version of Record online : 11 OCT 2011, DOI: 10.1111/j.1751-7176.2008.tb00041.x

  9. Modifications by Olmesartan medoxomil treatment of the platelet protein profile of moderate hypertensive patients

    PROTEOMICS - Clinical Applications

    Volume 2, Issue 9, No. 9 September 2008, Pages: 1300–1312, Daniel Sacristán, María Marques, José J Zamorano-León, Manuel Luque, Juan Armengol, Juan del Castillo, Javier Martín, Eva Delpón, Priscila Ramos-Mozo, Teresa P de Prada, Juan Tamargo, Alberto Barrientos, Carlos Macaya and Antonio López-Farré

    Version of Record online : 21 JUL 2008, DOI: 10.1002/prca.200700021

  10. The effects of colesevelam HCl on the single-dose pharmacokinetics of glimepiride, extended-release glipizide, and olmesartan medoxomil

    The Journal of Clinical Pharmacology

    Volume 54, Issue 1, January 2014, Pages: 61–69, Ling He, Prachi Wickremasingha, James Lee, Ben Tao, Jeanne Mendell-Harary, Joseph Walker and Douglas Wight

    Version of Record online : 12 OCT 2013, DOI: 10.1002/jcph.180

  11. Pharmacokinetics and safety of olmesartan medoxomil in combination with either amlodipine or atenolol compared to respective monotherapies in healthy subjects

    Fundamental & Clinical Pharmacology

    Volume 23, Issue 6, December 2009, Pages: 767–774, Juliane Bolbrinker, Matthias Huber, Jürgen Scholze and Reinhold Kreutz

    Version of Record online : 31 JUL 2009, DOI: 10.1111/j.1472-8206.2009.00720.x

  12. You have free access to this content
    Poster Abstracts

    The Journal of Clinical Hypertension

    Volume 11, Issue s1, April 2009, Pages: A16–A168,

    Version of Record online : 13 APR 2009, DOI: 10.1111/j.1751-7176.2009.00107.x

  13. You have free access to this content
    Antihypertensive Drugs and Pharmacology

    The Journal of Clinical Hypertension

    Volume 9, Issue 5SA, May 2007, Pages: A149–A189,

    Version of Record online : 10 OCT 2011, DOI: 10.1111/j.1751-7176.2007.tb00065.x

  14. You have free access to this content
    Long-Term Efficacy and Safety of Triple-Combination Therapy With Olmesartan Medoxomil and Amlodipine Besylate and Hydrochlorothiazide for Hypertension

    The Journal of Clinical Hypertension

    Volume 14, Issue 3, March 2012, Pages: 149–157, Dean J. Kereiakes, Steven G. Chrysant, Joseph L. Izzo Jr, Thomas Littlejohn III, Suzanne Oparil, Michael Melino, James Lee, Victor Fernandez and Reinilde Heyrman

    Version of Record online : 24 JAN 2012, DOI: 10.1111/j.1751-7176.2011.00588.x

  15. You have free access to this content
    The Effects of an Olmesartan Medoxomil–Based Treatment Algorithm on 24-Hour Blood Pressure Levels in Elderly Patients Aged 65 and Older

    The Journal of Clinical Hypertension

    Volume 11, Issue 8, August 2009, Pages: 411–421, Dean J. Kereiakes, Joel Neutel, Kathy A. Stoakes, William F. Waverczak, Jianbo Xu, Ali Shojaee and Robert Dubiel

    Version of Record online : 26 JUN 2009, DOI: 10.1111/j.1751-7176.2009.00147.x

  16. You have free access to this content
    Use of an Olmesartan Medoxomil-Based Treatment Algorithm for Hypertension Control

    The Journal of Clinical Hypertension

    Volume 6, Issue 4, April 2004, Pages: 168–399, Joel M. Neutel, 1 David H.G. Smith, 2,3 Micheal A. Weber, 4 Antonia C. Wang and 5 Harvey N. Masonson 5

    Version of Record online : 25 MAY 2007, DOI: 10.1111/j.1524-6175.2006.03304.x

  17. Analysis of Sartans: A Review

    Journal of Pharmaceutical Sciences

    Volume 103, Issue 1, January 2014, Pages: 2–28, Izabela Muszalska, Agnieszka Sobczak, Agnieszka Dołhań and Anna Jelińska

    Version of Record online : 13 NOV 2013, DOI: 10.1002/jps.23760

  18. The Use of Modeling and Simulation to Guide Clinical Development of Olmesartan Medoxomil in Pediatric Subjects

    Clinical Pharmacology & Therapeutics

    Volume 91, Issue 2, February 2012, Pages: 250–256, D E Salazar, S H Song, J Shi, S Rohatagi, R Heyrman, D R Wada and T J Carrothers

    Version of Record online : 28 DEC 2011, DOI: 10.1038/clpt.2011.220

  19. You have free access to this content
    Posters

    The Journal of Clinical Hypertension

    Volume 12, Issue s1, April 2010, Pages: A18–A147,

    Version of Record online : 1 APR 2010, DOI: 10.1111/j.1751-7176.2010.00282.x

  20. Olmesartan Medoxomil

    Standard Article

    Handbook of Metabolic Pathways of Xenobiotics

    Cheryl Black

    Published Online : 1 OCT 2014, DOI: 10.1002/9781118541203.xen222